US FDA Outlines Psychedelic Drug Trial Principles, But It Won’t Be An Easy Trip

psychedelic drugs
Among the recommendations in the FDA's new psychedelic drugs guidance is that a REMS could be imposed with approval. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D